A Randomised, Double-Blind, Placebo-Controlled, Multiple Administration Dose Escalation Phase IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of ABP2111Na Tablets in Overweight/Obese Subjects

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: ab96f7b783922fd8d71ccd3a27359987a4e8a12b
First added on: Apr 08, 2025